Changes in Novel AKI Biomarkers after Exercise. A Systematic Review.

Wojciech Wołyniec, Wojciech Ratkowski, Joanna Renke, Marcin Renke
Author Information
  1. Wojciech Wołyniec: Department of Occupational, Metabolic and Internal Diseases, Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, 9b Powstania Styczniowego Street, 81-519 Gdynia, Poland. ORCID
  2. Wojciech Ratkowski: Department of Athletics, Gdańsk University of Physical Education and Sport, 1 Górskiego Street, 80-336 Gdańsk, Poland.
  3. Joanna Renke: Department of General and Medical Biochemistry, University of Gdansk, 59 Wita Stwosza Street, 80-308 Gdańsk, Poland.
  4. Marcin Renke: Department of Occupational, Metabolic and Internal Diseases, Institute of Maritime and Tropical Medicine, Medical University of Gdańsk, 9b Powstania Styczniowego Street, 81-519 Gdynia, Poland. ORCID

Abstract

More than 100 substances have been identified as biomarkers of acute kidney injury. These markers can help to diagnose acute kidney injury (AKI) in its early phase, when the creatinine level is not increased. The two markers most frequently studied in plasma and serum are cystatin C and neutrophil gelatinase-associated lipocalin (NGAL). The former is a marker of kidney function and the latter is a marker of kidney damage. Some other promising serum markers, such as osteopontin and netrin-1, have also been proposed and studied. The list of promising urinary markers is much longer and includes cystatin C, NGAL, kidney injury molecule-1 (KIM-1), liver-type fatty-acid-binding protein (L-FABP), interleukin 18, insulin-like growth factor binding protein 7 (IGFBP-7), tissue inhibitor of metalloproteinases-2 (TIMP-2) and many others. Although these markers are increased in urine for no longer than a few hours after nephrotoxic agent action, they are not widely used in clinical practice. Only combined IGFBP-7/TIMP-2 measurement was approved in some countries as a marker of AKI. Several studies have shown that the levels of urinary AKI biomarkers are increased after physical exercise. This systematic review focuses on studies concerning changes in new AKI biomarkers in healthy adults after single exercise. Twenty-seven papers were identified and analyzed in this review. The interpretation of results from different studies was difficult because of the variety of study groups, designs and methodology. The most convincing data concern cystatin C. There is evidence that cystatin C is a better indicator of glomerular filtration rate (GFR) in athletes after exercise than creatinine and also at rest in athletes with a lean mass lower or higher than average. Serum and plasma NGAL are increased after prolonged exercise, but the level also depends on inflammation and hypoxia; therefore, it seems that in physical exercise, it is too sensitive for AKI diagnosis. It may, however, help to diagnose subclinical kidney injury, e.g., in rhabdomyolysis. Urinary biomarkers are increased after many types of exercise. Increases in NGAL, KIM-1, cystatin-C, L-FABP and interleukin 18 are common, but the levels of most urinary AKI biomarkers decrease rapidly after exercise. The importance of this short-term increase in AKI biomarkers after exercise is doubtful. It is not clear if it is a sign of mild kidney injury or physiological metabolic adaptation to exercise.

Keywords

References

  1. Am J Physiol Regul Integr Comp Physiol. 2019 Mar 1;316(3):R189-R198 [PMID: 30601706]
  2. Int J Sports Med. 2009 Sep;30(9):668-71 [PMID: 19544228]
  3. Ren Fail. 2020 Nov;42(1):154-165 [PMID: 32050834]
  4. Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F813-20 [PMID: 23825078]
  5. Scand J Med Sci Sports. 2020 Apr;30(4):709-715 [PMID: 31845418]
  6. J Clin Lab Anal. 2013 May;27(3):177-80 [PMID: 23686775]
  7. Clin Chem Lab Med. 2017 Jul 26;55(8):1074-1089 [PMID: 28076311]
  8. Nephron. 2018;138(1):29-34 [PMID: 28988230]
  9. Pediatr Res. 2018 May;83(5):1011-1015 [PMID: 29638229]
  10. Front Sports Act Living. 2020 Jan 21;1:71 [PMID: 33344994]
  11. Nephrology (Carlton). 2018 Nov;23(11):969-980 [PMID: 29806146]
  12. Br J Sports Med. 2013 Dec;47(18):1166-70 [PMID: 22773320]
  13. J Phys Act Health. 2018 Sep 1;15(9):679-682 [PMID: 30068247]
  14. Exerc Immunol Rev. 2013;19:29-48 [PMID: 23977718]
  15. Physiol Rep. 2018 Jun;6(12):e13749 [PMID: 29939499]
  16. Kidney Blood Press Res. 2012;36(1):278-89 [PMID: 23182776]
  17. J Clin Med. 2019 Sep 26;8(10): [PMID: 31561460]
  18. Int J Environ Res Public Health. 2020 Feb 19;17(4): [PMID: 32092895]
  19. J Am Soc Nephrol. 2007 Nov;18(11):2894-902 [PMID: 17942962]
  20. PLoS One. 2019 Sep 25;14(9):e0222544 [PMID: 31553742]
  21. Int J Environ Res Public Health. 2019 Oct 28;16(21): [PMID: 31661892]
  22. Ther Apher Dial. 2020 Dec;24(6):668-676 [PMID: 31997526]
  23. Am J Kidney Dis. 2018 Oct;72(4):475-482 [PMID: 30042041]
  24. Clin Chim Acta. 2015 Jan 1;438:350-7 [PMID: 25195004]
  25. BMJ Open Sport Exerc Med. 2017 Jul 06;3(1):e000241 [PMID: 29147573]
  26. Scand J Clin Lab Invest. 2012 Apr;72(2):114-20 [PMID: 22201455]
  27. Scand J Med Sci Sports. 2018 Jan;28(1):152-160 [PMID: 28247579]
  28. Clin J Sport Med. 2012 Sep;22(5):408-13 [PMID: 22744001]
  29. Scand J Med Sci Sports. 2020 Oct;30(10):1888-1895 [PMID: 32585737]
  30. Nephrology (Carlton). 2011 Feb;16(2):194-9 [PMID: 21272132]
  31. Saudi J Kidney Dis Transpl. 2008 Sep;19(5):721-9 [PMID: 18711286]
  32. Physiol Rep. 2017 Dec;5(24): [PMID: 29263119]
  33. Med Sci Sports Exerc. 2011 Oct;43(10):1819-27 [PMID: 21448080]
  34. Can Med Assoc J. 1933 Dec;29(6):598-604 [PMID: 20319319]
  35. Clin Chem Lab Med. 2012 Feb 14;50(9):1585-9 [PMID: 22962218]
  36. PLoS One. 2018 Nov 6;13(11):e0205791 [PMID: 30399190]
  37. Kidney Blood Press Res. 2016;41(5):680-700 [PMID: 27676272]
  38. J Am Med Assoc. 1956 Aug 25;161(17):1613-7 [PMID: 13345631]
  39. Emerg Med J. 2017 Oct;34(10):637-642 [PMID: 28679502]
  40. Scand J Clin Lab Invest. 1998 Nov;58(7):585-92 [PMID: 9890342]
  41. Eur J Appl Physiol. 2013 May;113(5):1249-55 [PMID: 23160657]
  42. Kidney Int. 2007 Mar;71(5):384-7 [PMID: 17191081]
  43. Nutrients. 2020 Jun 01;12(6): [PMID: 32492913]
  44. J Sci Med Sport. 2018 Dec;21(12):1180-1184 [PMID: 29784554]
  45. Am J Kidney Dis. 2018 Jul;72(1):129-135 [PMID: 29478865]
  46. Clin Chem. 1980 Jul;26(8):1119-26 [PMID: 6156031]
  47. Clin Nephrol. 2012 Jul;78(1):64-75 [PMID: 22732340]
  48. J Appl Physiol (1985). 2020 Apr 1;128(4):715-728 [PMID: 32078468]
  49. PLoS One. 2013 Aug 19;8(8):e71658 [PMID: 23977105]
  50. J Biol Regul Homeost Agents. ;31(3):829-835 [PMID: 28958144]
  51. Clin J Am Soc Nephrol. 2008 Mar;3(2):348-54 [PMID: 18235143]
  52. Exerc Immunol Rev. 2014;20:39-54 [PMID: 24974720]
  53. Cardiovasc Ultrasound. 2015 Mar 21;13:13 [PMID: 25889047]
  54. Crit Care. 2019 Jun 20;23(1):225 [PMID: 31221200]
  55. Bristol Med Chir J. 1989 Aug;104(3):63-7 [PMID: 2692780]
  56. Clin Exp Nephrol. 2017 Oct;21(5):810-817 [PMID: 28197733]
  57. BMJ Open Sport Exerc Med. 2017 Jun 14;3(1):e000093 [PMID: 29259804]
  58. BMC Nephrol. 2020 May 4;21(1):159 [PMID: 32366263]
  59. Am J Kidney Dis. 2017 Aug;70(2):252-261 [PMID: 28363731]
  60. BMC Nephrol. 2018 Dec 18;19(1):366 [PMID: 30563479]
  61. Dis Markers. 2013;35(5):537-42 [PMID: 24227892]
  62. Ann Clin Biochem. 2009 Sep;46(Pt 5):428 [PMID: 19721094]
  63. Physiol Rep. 2018 Jun;6(11):e13734 [PMID: 29890037]

MeSH Term

Acute Kidney Injury
Biomarkers
Exercise
Glomerular Filtration Rate
Humans

Chemicals

Biomarkers

Word Cloud

Created with Highcharts 10.0.0exerciseAKIkidneybiomarkersinjurymarkersincreasedNGALcystatinCurinaryacutemarkeralsoKIM-1studiesidentifiedhelpdiagnosecreatininelevelstudiedplasmaserumpromisinglongerproteinL-FABPinterleukin18manylevelsphysicalreviewathletescystatin-C100substancescanearlyphasetwofrequentlyneutrophilgelatinase-associatedlipocalinformerfunctionlatterdamageosteopontinnetrin-1proposedlistmuchincludesmolecule-1liver-typefatty-acid-bindinginsulin-likegrowthfactorbinding7IGFBP-7tissueinhibitormetalloproteinases-2TIMP-2othersAlthoughurinehoursnephrotoxicagentactionwidelyusedclinicalpracticecombinedIGFBP-7/TIMP-2measurementapprovedcountriesSeveralshownsystematicfocusesconcerningchangesnewhealthyadultssingleTwenty-sevenpapersanalyzedinterpretationresultsdifferentdifficultvarietystudygroupsdesignsmethodologyconvincingdataconcernevidencebetterindicatorglomerularfiltrationrateGFRrestleanmasslowerhigheraverageSerumprolongeddependsinflammationhypoxiathereforeseemssensitivediagnosismayhoweversubclinicalegrhabdomyolysisUrinarytypesIncreasescommondecreaserapidlyimportanceshort-termincreasedoubtfulclearsignmildphysiologicalmetabolicadaptationChangesNovelBiomarkersExerciseSystematicReview

Similar Articles

Cited By